Market Cap

Nautilus Biotechnology, Inc. Market Capitalization:

$221.0 Million

USD as of Jan. 1, 2025

business Nautilus Biotechnology, Inc. Company Profile

Nautilus Biotechnology, Inc. Main Stock Listing

NASDAQ: NAUT

Market Capitalization History of Nautilus Biotechnology, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
Novo Nordisk $622.07 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B

Yearly evolution of Nautilus Biotechnology, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $221.0 M -42.02%
Jan. 1, 2024 $381.2 M 60.84%
Jan. 1, 2023 $237.0 M -52.04%
Jan. 1, 2022 $494.1 M -65.16%
Jan. 1, 2021 $1.42 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Nautilus Biotechnology, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Nautilus Biotechnology, Inc. has the following listings and related stock indices.


Stock: NASDAQ: NAUT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.